| ID | Name | CAS | Properties |
logPoct/wat |
| 31-660-4 |
5«beta»-Cholane-3«alpha»,7«alpha»,12«alpha»,24-tetrol, TMS
|
|
2 | 10.793 |
| 31-663-1 |
Silane, diethyl(2,7-dimethyloct-1-en-3-yn-5-yloxy)nonyloxy-
|
|
2 | 7.246 |
| 31-712-6 |
3A,17A,20A,21-Tetrahydroxy-5B-pregnan-11-one, tetrakis-TMS
|
|
2 | 9.090 |
| 31-739-7 |
9H-purine-6(1h)-thione, 9-beta-d-ribofuranosyl-, 2',3'-diacetate, 5'-bis(3,5-dimethylphenyl)phosphate
|
|
2 | 5.284 |
| 31-777-5 |
5«beta»-Cholestane-3«alpha»,7«alpha»,12«alpha»-triol, TMS
|
|
2 | 10.598 |
| 31-814-3 |
ent-16«beta»,17-H2(OH)2 7«alpha»-OH kaurenolide, MeTMSi
|
|
2 | 7.206 |
| 31-825-1 |
4-Pyrimidineacetic acid, 6-amino-2-chloro-5-nitro-, ethyl ester
|
|
2 | 0.726 |
| 31-853-0 |
5-Cholesten-3-«beta»,7-«alpha»,12-«alpha»,24-tetrol, TMS
|
|
2 | 11.738 |
| 31-876-5 |
2-Naphthanilide, 4-[4-diethylamino-o-tolylimino]-1,4-dihydro-n-methyl-1-oxo-
|
121676-58-2 |
2 | 5.748 |
| 31-951-1 |
17-«alpha»-Hydroxy-7-«alpha»,17-«alpha»-dimethyl-5-«beta»-androstan-3-one, 17-TMS
|
|
2 | 6.454 |
| 32-009-6 |
*5«beta»-Pregnane-3«alpha», 20«beta»-diol-11-one, MO TMS
|
|
2 | 6.938 |
| 32-115-8 |
3-«beta»,18-Dihydroxy-5-androsten-17-one, MO TMS
|
|
2 | 7.003 |
| 32-127-5 |
5-«alpha»-Pregnan-20-«alpha»-ol-11-one, MO-TMS
|
|
2 | 6.888 |
| 32-143-7 |
D-Glucuronic acid, 2,3,4,5-tetrakis-O-(trimethylsilyl)-, trimethylsilyl ester
|
55530-80-8 |
2 | 5.444 |
| 32-144-6 |
6-tert-Butyl-2,4-bis(trimethylsilyl)-1,2,4-triazine-3,5-dione
|
|
2 | 2.068 |
| 32-183-3 |
5-Cholesten-3-«beta»,7-«alpha»,12-«alpha»,25-tetrol, TMS
|
|
2 | 11.882 |
| 32-213-9 |
Glycine, N-(trimethylsilyl)-N-[3-[(trimethylsilyl)oxy]benzoyl]-, trimethylsilyl ester
|
55517-54-9 |
2 | 4.556 |
| 32-257-1 |
Methyl 5-.beta.-cholan-3-.alpha.-ol-7-one-24-oate, oxime, TMS
|
|
2 | 8.272 |
| 32-411-9 |
Isomaltotriose: aD-Glcp(1->6)-aDGlcp(1->6)-DGlc, oxime-TMS, isomer # 2
|
|
2 | 14.359 |
| 32-422-7 |
D-Glucose, 2,3,4,5,6-pentakis-O-(trimethylsilyl)-
|
6736-97-6 |
2 | 5.917 |
| 32-650-4 |
Glycine, N-[1-[(tert-butyldimethylsilyl)oxy]propylidene]-, tert-butyldimethylsilyl ester
|
|
2 | 5.365 |
| 32-789-1 |
L-Cysteine, N,S-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
110024-94-7 |
2 | 7.237 |
| 33-022-0 |
Pyrrolidine, 1-(2,3-dihydro-4-pheynl-1(4h)-benzopyran-4-carbonyl)-
|
|
2 | 3.378 |
| 33-036-5 |
7-Chloro-3-methyl-quinoline-8-carboxylic acid, tert-butyldimethylsilyl ester
|
|
2 | 5.359 |
| 33-072-5 |
Indeno[1,2-c]pyrazol-4-one, 3-ethyl-, hydrazone
|
108952-68-7 |
2 | 1.182 |
| 33-075-2 |
cis-Anthracene, 1,2,3,4-tetrahydro-1,2-diol, methylboronate
|
|
2 | 3.360 |
| 33-103-0 |
trans-Anthracene, 1,2,3,4-tetrahydro-1,2-diol, bis-TMS
|
|
2 | 5.899 |
| 33-125-6 |
3-Iodo-L-tyrosine, N,O-bis(trimethylsilyl)-, trimethylsilyl ester
|
|
2 | 5.219 |
| 33-142-7 |
5.beta.-Pregnane-11,20-dione-3.alpha.,21-diol, EO-TMS, # 1
|
|
2 | 7.722 |
| 33-143-6 |
5.alpha.-Pregnane-11,20-dione-3.alpha.,21-diol, EO-TMS, # 2
|
|
2 | 7.722 |
| 33-512-6 |
ent-6«alpha»,7«alpha»,16«alpha»,17-(OH)4 KA, MeTMS
|
|
2 | 8.674 |
| 33-587-4 |
4,4'-Dibenzyl-[2,2'-azo-1,3,4-thiadiazol-5-one]
|
|
2 | 3.435 |
| 33-724-1 |
2-(3-Oxo-1,3-dihydro-2-benzofuran-1-yl)-1h-isoindole-1,3(2h)-dione
|
|
2 | 2.152 |
| 33-826-8 |
5«alpha»-Androstane-3«alpha»,16«alpha»,17«beta»-triol, TMS
|
|
2 | 8.299 |
| 33-903-2 |
9H-Purine-9-acetic acid, 6-[(p-chlorophenyl)amino)-, ethyl ester
|
101103-22-4 |
2 | 2.786 |
| 34-040-9 |
5-«beta»-Pregnan-3-«beta»,11-«beta»-diol-20-one, MO-TMS
|
|
2 | 7.718 |
| 34-113-8 |
3«alpha»,12«alpha»-Dihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl ether
|
|
2 | 9.115 |
| 34-237-1 |
3-Methyl-L-histidine, N-(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 4.474 |
| 34-293-9 |
L-(+)-Lactic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
2 | 4.945 |
| 34-422-5 |
1,2,4-Triazol-5(4H)-thione, 4-allyl-3-phenyl-
|
|
2 | 2.312 |
| 34-539-6 |
2-hydroxy-1,4-benzoxazin-3-one, N,O-bistrimethylsilyl
|
|
2 | 3.424 |
| 34-562-0 |
N,n'-diacetyl-n,n'-bis-[5-chloro-1,3,4-thiadiazolyl-2-]hydrazine
|
|
2 | 2.017 |
| 34-614-2 |
allo-5B-Pregnan-3A,11B,21-triol-20-one, MO TMS
|
|
2 | 8.549 |
| 34-631-3 |
5«alpha»-Androstan-17«alpha»-methyl-4«beta»,17«beta»-diol-3,2c-pyrazol, TMS
|
|
2 | 6.845 |
| 34-680-9 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-4.«alpha»,17«beta»-diol, bisTMTBS
|
|
2 | 10.734 |
| 34-885-2 |
Bolasterone M (5B-Androstan-7A,17A-dimethyl-3A,17B-diol), TMS
|
|
2 | 8.105 |
| 34-907-7 |
5-«beta»-Pregnan-3-«beta»,11-«beta»,20-«alpha»-triol, TMS
|
|
2 | 8.935 |
| 34-912-1 |
Urea, 1-(2-chloroethyl)-1-nitroso-3-(tetrahydrothiopyran-4-yl)-
|
33022-01-4 |
2 | 1.814 |
| 34-914-9 |
Silica-1,3,5,8-tetramethyl-2,4,6,7-tetraethylporphyrine complex, bis-OTMS
|
|
2 | 4.942 |
| 34-939-2 |
4'-Hydroxystanozolol (5A-Androstan-17A-methyl-4',17B-diol-3,2c-pyrazol), TMS
|
|
2 | 6.845 |
| 34-969-9 |
1-Aza-5-boratricyclo[3.3.3.01,5]undecane
|
|
2 | 1.960 |
| 35-001-1 |
Silane, dimethyl(2,6-dimethylnon-1-en-3-yn-5-yloxy)dodecyloxy-
|
|
2 | 8.027 |
| 35-181-2 |
Nicotinonitrile, 2-hydroxy-6-methyl-5-nitro-4-(trifluoromethyl)-, (keto form)
|
|
2 | 1.000 |
| 35-186-7 |
5«beta»-pregnane-3«alpha»,17«alpha»,20«beta»-triol, 3,17,20-tris-TMS
|
|
2 | 9.079 |
| 35-260-4 |
L-Selenomethionine, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
2 | 2.249 |
| 35-314-4 |
(3R)-3-Methyl-1,4-bis(trimethylsilyl)piperazine-2,5-dione
|
|
2 | 1.715 |
| 35-317-1 |
3,16,20-Tris[(trimethylsilyl)oxy]-5.alpha-pregnane, (3«beta»,16«alpha»,20«alpha»)-
|
33287-36-4 |
2 | 8.935 |
| 35-320-7 |
5-«alpha»-Pregnan-20-«beta»-ol-11-one, MO-TMS
|
|
2 | 6.888 |
| 35-413-4 |
3«alpha»,5«beta»,12«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, TMS
|
|
2 | 10.464 |
| 35-419-8 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-4.«alpha»,17«alpha»-diol, bisTMTBS
|
|
2 | 10.734 |
| 35-437-8 |
Silane, diphenyldi(1,1,1-trifluoro-3-bromoprop-2-yloxy)-
|
|
2 | 4.928 |
| 35-468-4 |
4-Chloro-N-(2-hydroxypropionyl)-benzenesulfonamide, N,O-di(tert.-butyldimethylsilyl)-
|
|
2 | 6.273 |
| 35-469-3 |
4-Pyridoxic acid, bis(tert-butyldimethylsilyl) ether, tert-butyldimethylsilyl ester
|
|
2 | 8.458 |
| 35-513-3 |
myo-Inositol, 1,2,3,4,5,6-hexakis-O-(trimethylsilyl)-
|
|
2 | 7.321 |
| 35-587-2 |
5-Chloro-1H-indole-2-carboxylic acid, tert-butyldimethylsilyl ester
|
|
2 | 4.501 |
| 35-604-2 |
Oxadiazole, 1,2,4-, 3-(morpholinomethyl)-5-(5-nitrofuran-2-yl)-
|
36133-75-2 |
2 | 1.070 |
| 35-775-3 |
5.alpha.-Stigmast-8(14)-en-3.beta.-ol, TMS
|
|
2 | 10.028 |
| 35-781-6 |
Methyl 5-.beta.-cholan-3,12-dione-24-oate, oxime, TMS
|
|
2 | 8.259 |
| 35-820-2 |
[(2-Ethyl-5-methylfuran-3,4-diyl)bis(oxy)]bis(trimethylsilane)
|
|
2 | 4.578 |
| 35-843-7 |
5-«alpha»-Pregnan-3-«beta»-ol-11-one, MO-TMS
|
|
2 | 6.888 |
| 35-880-6 |
cis-Phenanthrene, 9,10-dihydro-9-methyl-9,10-diol, butylboronate
|
|
2 | 4.959 |
| 35-936-4 |
4-Aminobenzoic acid, N- trifluoroacetyl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 6.749 |
| 35-964-3 |
2-(2,2-Dimethylpentoxy)-3-methyl-6-(n-heptyl) pyrazine
|
116660-34-5 |
2 | 5.503 |
| 35-996-8 |
1,3,5(10)-Oestratriene-2-methoxy-3,16«alpha»,17«beta»-triol, 3-TMS-16,17-PFP
|
|
2 | 7.594 |
| 35-998-6 |
S-triazine], 2,2'-cyclobut-1,2-ylene-bis[4,6-diamino-
|
19438-85-8 |
2 | -0.953 |
| 36-039-9 |
9H-purine, 2,6-difluoro-9-beta-d-xylofuranosyl-, 2',3',5'-triacetate
|
18354-15-9 |
2 | 0.428 |
| 36-045-2 |
ent-7-«alpha»,12-«beta»-Dihydroxykaurenonic acid, methyl ester, TMS
|
|
2 | 6.788 |
| 36-074-0 |
Silane, dimethyl(2,2,3,3,4,4,5,5-octafluoropentyloxy)pentyloxy-
|
|
2 | 5.083 |
| 36-090-2 |
(E/Z)-3.beta.,29-bis-(Trimethylsilyloxy)lup-20(29)-ene, # 1
|
|
2 | 11.063 |
| 36-246-9 |
3«beta»,17«beta»-Dihydroxy-5«alpha»-androstan-6-one, TMS
|
|
2 | 6.648 |
| 36-280-1 |
[(2-Ethyl-5-methylfuran-3,4-diyl)bis(oxy)]bis[tert-butyl(dimethyl)silane]
|
|
2 | 6.918 |
| 36-437-7 |
5-«beta»-Pregnan-3-«alpha»20-«beta»-diol-11-one, MO-TMS
|
|
2 | 7.718 |
| 36-670-8 |
5«alpha»-Androstane-3«beta»,7«alpha»,17«beta»-triol, TMS
|
|
2 | 8.299 |
| 36-697-9 |
5«alpha»-Androstane-3«alpha»,11«beta»,17«beta»-triol, TMS
|
|
2 | 8.299 |
| 36-725-7 |
N-(4-Morpholin-4-yl-phenyl)-2-nitro-benzenesulfonamide, N-trimethylsilyl-
|
|
2 | 3.462 |
| 36-745-5 |
4-Pregnen-3-«beta»,20-«alpha»-diol-11-one, MO-TMS
|
|
2 | 7.638 |
| 36-790-5 |
tert-Butyl-[2-[2-[2-[2-(tert-butyldimethylsilyl)oxyethoxy]ethoxy]ethoxy]ethoxy]dimethylsilane
|
|
2 | 5.080 |
| 36-819-3 |
cis-Phenanthrene, 9,10-dihydro-9-methyl-9,10-diol, 3,4-dimethoxy, bis-TMS
|
|
2 | 6.344 |
| 36-838-2 |
3«alpha»,7«alpha»,12«beta»-Trihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl ether
|
|
2 | 9.115 |
| 36-842-7 |
5«alpha»-Androst-16-en-3«beta»-ol trimethylsilyl ether
|
56210-81-2 |
2 | 6.415 |
| 36-898-6 |
1,1,1-trimethyl-N-((2E)-1-methyl-3-(trimethylsilyl)-4-[(trimethylsilyl)oxy]-1,3-dihydro-2H-imidazol-2-ylidene)silanamine
|
|
2 | 3.459 |
| 37-008-2 |
Ethyl 6-amino-4-chloro-5-nitro-2-pyridinyl(benzyl)carbamate
|
116403-17-9 |
2 | 3.388 |
| 37-022-6 |
5-«beta»-Pregnane-3«beta», 16«alpha», 20«alpha»-triol, MO TMS
|
|
2 | 8.935 |
| 37-204-4 |
Benzoic acid, 2-hydroxy-5-methyl-3-(1,1-dimethylethyl), DTBS
|
|
2 | 5.884 |
| 37-269-3 |
9H-purine-6(1h)-thione, 2-amino-9-beta-d-ribofuranosyl-, 2',3',5'-tribenzoate
|
|
2 | 3.795 |
| 37-309-8 |
2,2,4,4,6,6,8,10-octamethyl-8,10-diphenyl-[1,3,5,7,9,2,4,6,8,10]cyclopentasiloxane
|
|
2 | 4.147 |
| 37-554-6 |
5-«alpha»-Pregnane-3-«beta»,17-«alpha»,20-«alpha»-triol, tris-TMS
|
|
2 | 9.079 |
| 37-563-6 |
5-(3',3'-Dibutyl-1'-triazeno)-1,2,3-triazole-4-carboxamide
|
4342-10-3 |
2 | 1.323 |
| 37-587-0 |
13,14-Dihydro-15-keto-PGE2, EO-TMS, isomer # 3
|
|
2 | 8.483 |
| 37-595-1 |
5«alpha»-Androst-1-ene-3,17-dione, per-TMS
|
|
2 | 7.496 |
|
« Previous Results
Next Results »
|